“K2M is deeply committed to advancing care for scoliosis patients and we have developed technologies like MESA and Rail to put new capabilities into the hands of surgeons who treat the most complex spinal deformities,” said Eric Major, K2M president and CEO. “We are extremely pleased by the new indication and this milestone achievement allowing K2M to provide innovative solutions for surgeons treating pediatric patients.”
More Articles on Orthopedic Devices:
Will Medical Device Companies Benefit From Healthcare Reform?
7 Ways to Market Artificial Discs in Spine Practices
TranS1 Names Dr. Stephanie Fitts Vice President of Regulatory, Quality and Compliance
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.